Regeneron will invest $1.8 billion over six years to expand its manufacturing, support, and research facilities in New York. According to a press release from the New York Governor’s office, Regeneron plans to expand its R&D facilities at the firm’s Westchester Country Campus in Tarrytown. The investment encompasses Regeneron’s plans that were announced in April to inject $480 million to construct a preclinical facility at its Tarrytown campus. “This new investment in our workforce and laboratory spaces will allow for…

Recipharm will build a fill-finish facility in Uttarakhand, India increasing its fill-finish capacity to one billion sterile units per year. Contract development manufacturing organization (CDMO) Recipharm will construct the new facility on a greenfield site located near Dehradun in Uttarakhand as part of a joint project with Sobti. The Uttarakhand facility is the latest development in Recipharm’s partnership with Sobti, which began in November 2019 when the CDMO invested in Nichepharm. “This is part of our strategy to increase our…

Thermo Fisher Scientific has set out to capture a larger share of the growing DNA therapy and RNA vaccine market with a new facility in California. The facility – a 67,000-square-foot facility located at Thermo’s Carlsbad campus – will supply plasmid DNA for drug candidates in clinical trials as well as commercial supply. The firm cited growing global demand for plasmid DNA-based therapies and vital mRNA-based vaccines as the driver for the investment. CEO Marc Casper said, “Demand for commercial plasmid DNA…